<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Consilium Medicum</journal-id><journal-title-group><journal-title xml:lang="en">Consilium Medicum</journal-title><trans-title-group xml:lang="ru"><trans-title>Consilium Medicum</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title>Consilium Medicum</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2075-1753</issn><issn publication-format="electronic">2542-2170</issn><publisher><publisher-name xml:lang="en">Consilium Medicum</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">92968</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Spektr narusheniy sostoyaniya kostnoy tkani u bol'nykh III i IV stadiy khronicheskoy bolezni pochek</article-title><trans-title-group xml:lang="ru"><trans-title>Спектр нарушений состояния костной ткани у больных III и IV стадий хронической болезни почек</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ermolenko</surname><given-names>V. M</given-names></name><name xml:lang="ru"><surname>Ермоленко</surname><given-names>В. М</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mikhaylova</surname><given-names>N. A</given-names></name><name xml:lang="ru"><surname>Михайлова</surname><given-names>Н. А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Baterdene</surname><given-names>S.</given-names></name><name xml:lang="ru"><surname>Батэрдэнэ</surname><given-names>С.</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en"></institution></aff><aff><institution xml:lang="ru">Российская медицинская академия последипломного образования, Москва</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-07-15" publication-format="electronic"><day>15</day><month>07</month><year>2009</year></pub-date><volume>11</volume><issue>7</issue><issue-title xml:lang="en">VOL 11, NO7 (2009)</issue-title><issue-title xml:lang="ru">ТОМ 11, №7 (2009)</issue-title><fpage>17</fpage><lpage>23</lpage><history><date date-type="received" iso-8601-date="2021-12-28"><day>28</day><month>12</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2009, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2009, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2009</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://consilium.orscience.ru/2075-1753/article/view/92968">https://consilium.orscience.ru/2075-1753/article/view/92968</self-uri><abstract xml:lang="ru"><p>Нарушения минерального и костного метаболизма свойственны больным, страдающим хронической болезнью почек (ХБП), однако большинство исследований касается больных с V стадией заболевания, получающих заместительную почечную терапию (ЗПТ), и лишь относительно небольшое количество исследований, опубликованных в последние 10 лет, посвящено изучению фосфорно-кальциевого обмена и состоянию костной ткани у додиализного контингента. Недостатком этих исследований является неоднородность изучаемой популяции по степени снижения скорости клубочковой фильтрации (СКФ; от 80 до 5 мл/мин), по возрасту (от 18 до 80 лет), по нозологическим формам (включение больных с системными заболеваниями или длительной и массивной глюкокортикоидной терапией в анамнезе). Как следствие результаты этих исследований довольно противоречивы и не позволяют сделать обоснованные выводы о распространенности, степени выраженности и вариантах нарушения костного метаболизма у больных c ХБП III–IV стадии, не нуждающихся в ЗПТ. Мы попытались избежать указанных недостатков и получить максимально объективные данные о состоянии фосфорно-кальциевого обмена и костной ткани у больных с ХБП III и IV стадии.</p></abstract></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Клинические рекомендации. Остеопороз. Диагностика, профилактика и лечение. Под ред. О.М.Лесняк, Л.И.Беневоленской. М.: Гоэтар - Медиа, 2009; 204–18.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Михайлов Е.Е., Беневоленская Л.И., Мылов Н.М. Распространенность переломов позвоночника в популяционной выборке лиц 50 лет и старше. Вестн. травматол. и ортопед. им. Н.Н.Приорова, 1997; 3: 20–7.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Ahmed A.I.H., Blake G.M., Rymer J.M., Fogelman I. Screening for osteopenia and osteoporosis: Do accepted normal rangeslead to overdiagnosis? Osteoporosis Int 1997; 7: 432–8.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Bonnic S.L. Bone Densitometry in Clinical Practice. Humana Press Inc. 2004.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Brown J.P., Josse R.G. Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002; 167 (10 suppl.): S51–34.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Coen G, Mazzaferro S, Ballanti P et al. Renal bone disease in 76 patients with varying degees of predialysis chronic renal failure: a cros - sectional study. NDT 1996; 11: 813–9.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Craver L, Marco M, Martinez I et al. Mineral metabolism parameters throughout chronic kidney disease stages 1–5 achivement of K/DOQI taget ranges. NDT 2007; 22: 1171–5.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Gomes K.P., Barello Silva M.I., Lette Duarte M.E. et al. Bone disease in patients with chronic kidney disease under conservative management. Sao Paulo Med J 2005; 123: 83–7.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Holick M.F. Vitamin D for health and in chronic kidney disease. Semin Dial 2005; 18: 266–75.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Khan A.A., Hodsman A.B., Papaioannou A et al. Management of osteoporosis in men: an update and case example. 2007.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Lobo R, Carvalho A.B., Cuppari L et al. High prevalence of low bone mineral density in pre - dialysis chronic kidney disease patients: bone histomorphometric analysis. Clin Nephrol 2004; 62 (6): 432–9.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Menon V, Greene T, Pereira A et al. Relationship of phosphorus and calcium - phosphorus product with mortality in CKD. Am J Kidney Dis 2005; 46: 455–63.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Neves K.R., Graciolli F.G., dos Reis L.M. et al. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function and bone in rats with renal failure. Kidney Int 2004; 66: 2237–44.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>NKF-K/DOQI Clinical Practice Guidelinesfor bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1–201.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Official Positions of the International Societyfor Clinical Densitometry. Copyright ISCD, October 2007, Supersedes all prior «Official positions» publications.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Ramos A.M., Albalate M, Vazquez S et al. Hyperphosphatemia and hyperparathyroidism in incident chronic kidney disease patients. Kidney Int 2008; 74 (Suppl. 111): S88–93.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Rix M, Andreassen H, Eskildsen P et al. Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure. Kidney Int 1999; 56: 1084–93.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Shin S.K., Kim D.N., Kim H.S. et al. Renal osteodistrophy in pre - dialysis patients: ethnic difference? Proceedings of the ICPD’98 – The VIIIth Congress of the ISPD, August 23–26, 1998, Seoul, Korea. Copyright &amp; copy: 1999 International Society for Peritoneal Dialysis. Printed in Canada.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Varenna M, Binelli L, Zucchi F et al. Prevalence of osteoporosis by educational level in cohortof menopausal women. Osteoporosis Int 1999; 9: 236–41.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Voormolen N, Noordzij M, Grootendorst D et al. The PREPARE study group. High plasma phosphate as a risk factor for decline in renal function and mortality in pre - dialysis patients. NDT 2007; 22: 2909–16.</mixed-citation></ref></ref-list></back></article>
